ISA 2024 | Key unmet needs that remain in frontline AL amyloidosis
Maximilian Steinhardt, MD, University Hospital Würzburg, Würzburg, Germany, discusses key unmet needs in frontline light chain (AL) amyloidosis. Whilst there have been some improvements, the main unmet need remains early diagnosis, as this can impact the quality of life of patients, the treatments they receive, and more generally, their outcome. Additionally, there are still gaps in the knowledge of how to best treat patients to secure a deep, fast, and long-lasting remission, and how to approach patients who do not go into quick remission. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Travel funds from Janssen
